Evaluation of treatment of shigellosis and salmonellosis with chloromycetin, glucomycin, and sulfasuxidine.
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D002701:Chloramphenicol / Q000627:therapeutic use*; D003879:Dermatologic Agents; D004405:Dysentery, Bacillary / Q000628:therapy*; D006801:Humans; D012478:Salmonella Food Poisoning; D012480:Salmonella Infections / Q000628:therapy*; D012760:Shigella; D000077589:Sulfathiazole; D013432:Sulfathiazoles / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D013432:Sulfathiazoles; D002701:Chloramphenicol; C009342:succinylsulfathiazole; D000077589:Sulfathiazole
ANTIBIOTICS; CHLORAMPHENICOL/therapeutic use; SALMONELLA INFECTIONS/therapy; SHIGELLA INFECTIONS/therapy; SULFATHIAZOLE/therapeutic use